Abstract
- Types 16 and 18 are the most widely studied high-risk types of human papillomavirus (HPV). However, other high-risk HPV types (HPV non-16/18) also play a significant role in cervical neoplasia. Currently, screening and management algorithms separate out HPV 16/18 from all other HPV non-16/18 types. In addition, most of the previously vaccinated population has only been vaccinated for these high-risk types, so many women are still vulnerable to HPV non-16/18 infections. - To review the prevalence and role of HPV non-16/18 neoplasia and to review current surveillance, management, and vaccination strategies in view of these findings. - The study comprised a review of the literature. - Although HPV non-16/18 types are less frequently associated with cervical intraepithelial neoplasia and cancer, they are nonetheless a significant cause of disease. Further stratification of higher-risk HPV non-16/18 may be necessary to improve prevention and management, however, regional prevalence differences may make a unified approach difficult. As HPV 16/18 infections decrease owing to vaccination of at-risk women, the relative frequency of HPV non-16/18 will increase, although the latest vaccine covers several more high-risk types.
References
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gary M CliffordJeanne M Pimenta
Oct 20, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anna K WongShikha Bose
Nov 13, 2009·Gynecologic Oncology·Nathalie Dauphin McKenzieJoseph A Lucci
Jul 31, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Karin SundströmNathalie Ylitalo
Oct 19, 2010·The Lancet Oncology·Silvia de SanjoseUNKNOWN Retrospective International Survey and HPV Time Trends Study Group
Mar 15, 2011·Gynecologic Oncology·Mario SideriMaria Teresa Sandri
Apr 26, 2012·International Journal of Cancer. Journal International Du Cancer·Cosette M WheelerUNKNOWN New Mexico HPV Pap Registry Steering Committee
Dec 12, 2012·Cancer Cytopathology·Ming GuoNour Sneige
Mar 27, 2013·Journal of Lower Genital Tract Disease·L Stewart MassadUNKNOWN 2012 ASCCP Consensus Guidelines Conference
Jun 15, 2014·International Journal of STD & AIDS·Deepa ReddyRisa M Hoffman
Oct 9, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Buasorn SuphoChumnan Kietpeerakool
Dec 17, 2014·BMC Infectious Diseases·Rocío Méndez-MartínezAlejandro García-Carrancá
Feb 11, 2015·Gynecologic Oncology·Joseph MonsonegoWarner Huh
Apr 24, 2015·Cancer Cytopathology·Yasmin A LyonsYimin Ge
Aug 22, 2015·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·L C SnymanF H van der Merwe
Nov 1, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Mary C CambouBeatriz Grinsztejn
Oct 25, 2016·Journal of Gynecologic Oncology·Yeoun Eun SungJong Sup Park
Jan 19, 2017·The American Journal of Surgical Pathology·Yiang HuiLi Juan Wang
Jun 12, 2017·BMJ Open·Hui Hui XuWei Hua Yan
Sep 17, 2017·Cancer Prevention Research·Li DongFang-Hui Zhao
Nov 22, 2017·Archives of Pathology & Laboratory Medicine·Siavash Azadmanesh SamimiYimin Ge
Citations
Jul 8, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Xueliang WangHualiang Wang
May 23, 2019·Human Vaccines & Immunotherapeutics·Yan Geng, Liyan Liu
Nov 2, 2019·PloS One·Jiyoung Kim, Sun-Young Jun
Dec 4, 2019·Oncology Letters·Xing GuQin Liu
Aug 28, 2021·Biology·Gulzhanat AimagambetovaTorgyn Issa